{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe final concentration of [<sup>3</sup>H]nicotine was 5 nM.\nNon-specific binding was determined by inclusion of 10 \u03bcM non-radioactive L-nicotine (Acros Organics) in selected wells.\nInhibition constants (Ki values), reported in nM, were calculated from the IC<sub>50 </sub>values using the method of Cheng et al., Biochem. Pharmacol. 22: 3099 (1973).\nPMSF, dissolved in methanol to a final concentration of 100 \u03bcM, was added and the tissue suspension was homogenized by Polytron."}
{"final_json": [{"molecule_name": "[<sup>3</sup>H]nicotine", "protein_target_name": null, "binding_metric": null, "value": "5", "unit": "nM"}, {"molecule_name": "L-nicotine", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "PMSF", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe inhibition of [<sup>3</sup>H]MLA binding by test compounds was determined by including seven different concentrations of the test compound in selected wells, and IC<sub>50 </sub>values were estimated as the concentration of compound that inhibited 50 percent of specific [<sup>3</sup>H]MLA binding.\nInhibition constants (Ki values), reported in nM, were calculated from the IC<sub>50 </sub>values using the method of Cheng et al., Biochem. Pharmacol. 22: 3099-3108 (1973).\nThe final concentration of [<sup>3</sup>H]MLA was 5 nM.\nNon-specific binding was determined by inclusion of 50 \u03bcM non-radioactive MLA in selected wells."}
{"final_json": [{"molecule_name": "[<sup>3</sup>H]MLA", "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "[<sup>3</sup>H]MLA", "protein_target_name": null, "binding_metric": null, "value": "5", "unit": "nM"}, {"molecule_name": "MLA", "protein_target_name": null, "binding_metric": null, "value": "50", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences:\n\nThe biological data indicate that the compounds of the present invention have the ability to selectively bind with high affinity to the \u03b17 (Ki values from 300 \u03bcM to 10 \u03bcM) and \u03b14\u03b22 (Ki values from 100 pM to 24 nM) receptors, as indicated by relatively low binding constants, and in some cases bind at concentrations well below those concentrations required for activation of muscle or ganglionic receptors.\nFurthermore, the data indicate that certain of these compounds do not cause any appreciable side effects at muscle sites or ganglionic sites at concentrations effective for producing CNS effects or neurotransmitter release (as low as 30 nM for dopamine release), thus indicating a lack of undesirable side effects in subjects receiving administration of those compounds at dose ranges at which CNS effects and neurotransmitter release are elicited."}
{"final_json": [{"molecule_name": null, "protein_target_name": "\u03b17 receptor", "binding_metric": "Ki", "value": "300 \u03bcM", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "\u03b17 receptor", "binding_metric": "Ki", "value": "10 \u03bcM", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "\u03b14\u03b22 receptor", "binding_metric": "Ki", "value": "100 pM", "unit": "pM"}, {"molecule_name": null, "protein_target_name": "\u03b14\u03b22 receptor", "binding_metric": "Ki", "value": "24 nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "30 nM", "unit": "nM"}]}
